A Safety Review and Meta-Analyses of Bevacizumab and Ranibizumab: Off-Label versus Goldstandard

• Christine Schmucker ,

  * E-mail: schmucker@cochrane.de

  Affiliation German Cochrane Institute, Institute of Medical Biometry and Medical Informatics, Department of Medical Biometry and Statistics, University Medical Centre Freiburg, Freiburg, Germany

  ⨯
• Christoph Ehlken,

  Affiliation University Eye Hospital, University Medical Centre Freiburg, Freiburg, Germany

  ⨯
• Hansjuergen T. Agostini,

  Affiliation University Eye Hospital, University Medical Centre Freiburg, Freiburg, Germany

  ⨯
• Gerd Antes,

  Affiliation German Cochrane Institute, Institute of Medical Biometry and Medical Informatics, Department of Medical Biometry and Statistics, University Medical Centre Freiburg, Freiburg, Germany

  ⨯
• Gerta Ruecker,

  Affiliation Institute of Medical Biometry and Medical Informatics, Department of Medical Biometry and Statistics, University Medical Centre Freiburg, Freiburg, Germany

  ⨯
• Monika Lelgemann,

  Affiliation Medical Advisory Service of the German Health Insurance Funds, Essen, Germany

  ⨯
• Yoon K. Loke

  Affiliation School of Medicine, University of East Anglia, Norwich, United Kingdom

  ⨯